Library
PubMed
research article
Professional

Anaphylactic risk due to systemic mastocytosis: Perioperative management in cardiac surgery.

Source: PubMed, NCBI / U.S. National Library of Medicine

Revista espanola de anestesiologia y reanimacionMartín Serrano P, Martín Hernández J G, Martín Celemín R, et al.Published 1/1/2019Last synced 6/6/2026Status: syncedPMID: 30850182DOI: 10.1016/j.redar.2019.01.008

Mastocytosis is a disease characterised by an abnormal proliferation of mast cells. The degranulation of mast cells can be triggered by chemical, physical, and psychological factors, and in severe cases may be accompanied by cardiovascular alterations and shock. Tryptase concentrations greater than 20ug/L may be associated with an increased risk of mastocyte degranulation. The case is presented on a 71 year-old man that underwent an aortic valve replacement and aortic-coronary bypass surgery. He had an indolent systemic mastocytosis and a history of histaminergic crises, with a baseline value of tryptase prior to surgery of 58.1ug/L.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.